{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T08:44:33Z","timestamp":1768725873016,"version":"3.49.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>Galectin-3 has been suggested relative to tumor genesis, progression, and metastasis in basal cell carcinoma and squamous cell carcinoma that are the most common skin cancers characterized by malignant epidermal proliferation. In this study, we evaluated galectin-3 expression in seborrheic keratosis, keratoacanthoma, and infectious diseases including verruca vulgaris, condyloma acuminatum, and chromoblastomycosis that are pathologically featured by benign epidermal proliferation. Galectin-3 expression was shown by immunohistochemical staining and quantified using the Image Pro Plus V6.0. We found that galectin-3 distributed evenly in normal skin around the body decreased significantly in all selected diseases compared with healthy controls, but it was comparable among each disease. These findings imply that galectin-3 do not differentiate between benign and malignant proliferation of keratinocytes.<\/jats:p>","DOI":"10.1097\/dad.0000000000000781","type":"journal-article","created":{"date-parts":[[2016,12,6]],"date-time":"2016-12-06T16:13:23Z","timestamp":1481040803000},"page":"738-741","source":"Crossref","is-referenced-by-count":11,"title":["Galectin-3 Expression in Benign and Malignant Skin Diseases With Epidermal Hyperplasia"],"prefix":"10.1097","volume":"39","author":[{"given":"Ze-xin","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-zhen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen-rui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-fang","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangchun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230908","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jdermsci.2011.07.008","article-title":"Galectin-3 and the skin","volume":"64","author":"Larsen","year":"2011","journal-title":"J Dermatol Sci."},{"key":"R2-20230908","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1177\/1535370215593826","article-title":"Galectin-3 in autoimmunity and autoimmune diseases","volume":"240","author":"de Oliveira","year":"2015","journal-title":"Exp Biol Med."},{"key":"R3-20230908","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1038\/jid.2012.211","article-title":"Galectin-3 regulates intracellular trafficking of EGFR through Alix and promotes keratinocyte migration","volume":"132","author":"Liu","year":"2012","journal-title":"J Invest Dermatol."},{"key":"R4-20230908","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.canlet.2011.09.003","article-title":"Galectin-3\u2013a jack-of-all-trades in cancer","volume":"313","author":"Newlaczyl","year":"2011","journal-title":"Cancer Lett."},{"key":"R5-20230908","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.bbamcr.2015.08.008","article-title":"Galectin 3 as a guardian of the tumor microenvironment","volume":"1863","author":"Ruvolo","year":"2016","journal-title":"Biochim Biophys Acta."},{"key":"R6-20230908","first-page":"247","article-title":"Regulated expression of galectin-3, a multifunctional glycan-binding protein, in haematopoietic and non-haematopoietic tissues","volume":"26","author":"Sundblad","year":"2011","journal-title":"Histol Histopathol."},{"key":"R7-20230908","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1600-0625.1994.tb00260.x","article-title":"Expression of epsilon BP, a beta-galactoside-binding soluble lectin, in normal and neoplastic epidermis","volume":"3","author":"Konstantinov","year":"1994","journal-title":"Exp Dermatol."},{"key":"R8-20230908","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1158\/0008-5472.CAN-12-2424","article-title":"Galectin-3 contributes to melanoma growth and metastasis via regulation of NFAT1 and autotaxin","volume":"72","author":"Braeuer","year":"2012","journal-title":"Cancer Res."},{"key":"R9-20230908","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.ejca.2011.09.003","article-title":"Association of galectin-3 expression with melanoma progression and prognosis","volume":"48","author":"Brown","year":"2012","journal-title":"Eur J Cancer."},{"key":"R10-20230908","doi-asserted-by":"crossref","first-page":"6709","DOI":"10.1158\/1078-0432.CCR-06-0758","article-title":"Galectin-3 expression is associated with tumor progression and pattern of sun exposure in melanoma","volume":"12","author":"Prieto","year":"2006","journal-title":"Clin Cancer Res."},{"key":"R11-20230908","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.prp.2008.09.001","article-title":"Immunohistochemical galectin-3 expression in non-melanoma skin cancers","volume":"205","author":"Kapucuoglu","year":"2009","journal-title":"Pathol Res Pract."},{"key":"R12-20230908","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/0961203313513820","article-title":"The association of anti-annexin1 antibodies with the occurrence of skin lesions in systemic lupus erythematosus","volume":"23","author":"Meng","year":"2014","journal-title":"Lupus"},{"key":"R13-20230908","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.biopha.2016.01.014","article-title":"Molecular regulation of galectin-3 expression and therapeutic implication in cancer progression","volume":"78","author":"Wang","year":"2016","journal-title":"Biomed Pharmacother."},{"key":"R14-20230908","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1158\/0008-5472.CAN-04-3578","article-title":"Effects of DNA methylation on galectin-3 expression in pituitary tumors","volume":"65","author":"Ruebel","year":"2005","journal-title":"Cancer Res."},{"key":"R15-20230908","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/nm.2865","article-title":"Untuning the tumor metabolic machine: HIF-alpha: pro- and antitumorigenic?","volume":"18","author":"Young","year":"2012","journal-title":"Nat Med."},{"key":"R16-20230908","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4137\/CMO.S29462","article-title":"Galectin-3 as a potential target to prevent cancer metastasis","volume":"9","author":"Ahmed","year":"2015","journal-title":"Clin Med Insights Oncol."},{"key":"R17-20230908","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.humimm.2015.09.036","article-title":"Role of galectin-3 in the pathogenesis of bladder transitional cell carcinoma","volume":"76","author":"Zeinali","year":"2015","journal-title":"Hum Immunol."},{"key":"R18-20230908","first-page":"67","article-title":"Decreased expression of galectin-3 in basal cell carcinoma of the skin","volume":"15","author":"Castronovo","year":"1999","journal-title":"Int J Oncol."},{"key":"R19-20230908","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ijc.11072","article-title":"Frequent downregulation of DMBT1 and galectin-3 in epithelial skin cancer","volume":"105","author":"Mollenhauer","year":"2003","journal-title":"Int J Cancer."},{"key":"R20-20230908","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1038\/jid.2008.119","article-title":"Galectin-3 protects keratinocytes from UVB-induced apoptosis by enhancing AKT activation and suppressing ERK activation","volume":"128","author":"Saegusa","year":"2008","journal-title":"J Invest Dermatol."}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000372-201710000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T04:06:30Z","timestamp":1694145990000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000372-201710000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000000781","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]}}}